Partner of Boston Millennia Partners

Rob invests in high growth companies in healthcare and business services. He is currently serves as a Director of Novalar Pharmaceuticals, a dental anesthetic reversal agent company, Athenix Corporation which creates insect and herbicide resistant plants, PHT, which enables patient self reporting in clinical trials and iParty (AMEX:IPT), a specialty retailer headquartered in New England. Additional investment responsibilities included Hotjobs.com (acquired by Yahoo, NASDAQ: YHOO), Proteome, (acquired by Incyte, NASDAQ:INCY), eMed (sold to Cedara (TO: CDE) and Galt Associates (acquired by Cerner (NASDQ: CERN), Protein Forest and MegaPath. Previous experience includes Bolt, Beranek and Newman where he served as Controller of the Communications Division and CFO of the Airline Reservation Systems subsidiary in Copenhagen. Earlier he held Financial Management positions at General Electric and Puritan Life Insurance Company.

Rob is a graduate of Haverford College and holds an MBA from the Amos Tuck School at Dartmouth College.